Search - tctmd.com

Displaying 381 - 400 of 1866

Sort: Relevancy | Date

News Daily News

ATTRibute-CM Top-Line Results Favorable for Acoramidis

L.A. McKeown

July 17, 2023

News Daily News

CMS Issues Proposed Coverage Decision to Broaden Access for Carotid Stenting

L.A. McKeown

July 12, 2023

News Daily News

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Michael O'Riordan

July 12, 2023

News Daily News

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Michael O'Riordan

July 11, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

Over Decades, Women Still Missing in NIH-Funded Trials for CVD

Caitlin E. Cox

June 30, 2023

News Conference News ADA 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

L.A. McKeown

June 28, 2023

News Conference News ADA 2023

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Michael O'Riordan

June 28, 2023

News Daily News

PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains

Shelley Wood

June 22, 2023

News Daily News

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Michael O'Riordan

June 22, 2023

News Daily News

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Caitlin E. Cox

June 21, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Daily News

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

Todd Neale

June 20, 2023

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Daily News

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Michael O'Riordan

June 19, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Conference News TVT 2023

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

Shelley Wood

June 14, 2023

News Daily News

Lipid Panels in Standard Precath Blood Draws? Researchers Say It’s Time

Todd Neale

June 13, 2023

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

L.A. McKeown

June 09, 2023

Advertisement

ATTRibute-CM Top-Line Results Favorable for Acoramidis

CMS Issues Proposed Coverage Decision to Broaden Access for Carotid Stenting

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

Over Decades, Women Still Missing in NIH-Funded Trials for CVD

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

FDA Approves Colchicine for Decreasing CV Events

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

Lipid Panels in Standard Precath Blood Draws? Researchers Say It’s Time

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content